 |
|
|
| |
Distribution of Active PrEP Prescriptions and the PrEP-to-Need Ratio, US Q2 2017
|
| |
| |
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Aaron J. Siegler, PhD1; Farah Mouhanna, MS1,2; RobertinoGiler-Mera, MD, PhD3; Howa Yeung, MD1; Jeb Jones, PhD1; Jodie L. Guest, PhD1,4;Michael Kramer, PhD1; Cory Woodyatt, BSN, RN1; Elizabeth Pembleton, MPH1; Patrick S. Sullivan, PhD1
1Department of Epidemiology, Rollins School of Public Health, Emory University, 1518 Clifton Rd NE, Atlanta, GA, 30322 USA 2. Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, The George Washington University, 950 New Hampshire Ave NW, Washington, DC 20052 USA. 3. Pharmacovigilance & Epidemiology, Gilead Sciences, 333 Lakeside Drive, Foster City, CA, 94404 USA 4.Department of Family and Preventive Medicine, School of Medicine, Emory University, 1462 Clifton Rd NE, Atlanta, GA, 30322 USA.
|
| |
|
|
|
|
|
